CHICAGO--(BUSINESS WIRE)--GSL Biotech and VectorBuilder have formed a partnership to create a complete cloning solution, allowing customers to order their entire custom plasmids directly from ...

Our ability to cut and paste DNA from different sources and to assemble it into gene constructs has been one of the key drivers of biological research and biotechnology over the past four decades.

VectorBuilder, a global leader in gene delivery technologies and CDMO services, today announced the publication of the miniVec plasmid system, engineered for safer, more efficient, and more scalable ...

As a lab within the Cooperative Center of Excellence in Hematology (CCEH) at Fred Hutch, the Vector Production core assists investigators with the design, construction, and/or production of viral ...

Since the late 1990s, Charles Venditti, M.D., Ph.D., senior investigator with the National Human Genome Research Institute of the NIH, has been studying a group of rare and devastating pediatric ...

If gene therapies are to realize their enormous therapeutic and commercial potential, they will need well-designed delivery vehicles—and lots of them. In the near term, most of these vehicles will ...

SAN DIEGO--(BUSINESS WIRE)--SGI-DNA announces the launch of the Multi-Tile Assembly Cloning (MTAC) application for its BioXp™ 3200 System, providing scientists with the ability to synthesize two genes ...

A new, simplified method for producing large amounts of viral vector cassettes capable of shuttling genes into host cells will help advance the promising field of gene therapy as applications move ...

Dublin, July 09, 2025 (GLOBE NEWSWIRE) -- The "Viral Vectors & Plasmid DNA Manufacturing Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering. The global Viral Vectors and ...

Ottawa, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The global viral vectors and plasmid DNA manufacturing market size surpassed USD 6.26 billion in 2024 and is estimated to grow from USD 7.26 billion in 2025 ...